513 related articles for article (PubMed ID: 22982064)
1. Fibroblasts in post-infarction inflammation and cardiac repair.
Chen W; Frangogiannis NG
Biochim Biophys Acta; 2013 Apr; 1833(4):945-53. PubMed ID: 22982064
[TBL] [Abstract][Full Text] [Related]
2. Fibroblasts in myocardial infarction: a role in inflammation and repair.
Shinde AV; Frangogiannis NG
J Mol Cell Cardiol; 2014 May; 70():74-82. PubMed ID: 24321195
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction.
Tillmanns J; Hoffmann D; Habbaba Y; Schmitto JD; Sedding D; Fraccarollo D; Galuppo P; Bauersachs J
J Mol Cell Cardiol; 2015 Oct; 87():194-203. PubMed ID: 26319660
[TBL] [Abstract][Full Text] [Related]
4. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
5. Properties and Functions of Fibroblasts and Myofibroblasts in Myocardial Infarction.
Venugopal H; Hanna A; Humeres C; Frangogiannis NG
Cells; 2022 Apr; 11(9):. PubMed ID: 35563692
[TBL] [Abstract][Full Text] [Related]
6. The extracellular matrix modulates fibroblast phenotype and function in the infarcted myocardium.
Dobaczewski M; de Haan JJ; Frangogiannis NG
J Cardiovasc Transl Res; 2012 Dec; 5(6):837-47. PubMed ID: 22956156
[TBL] [Abstract][Full Text] [Related]
7. Role of miR-145 in cardiac myofibroblast differentiation.
Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK
J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939
[TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
9. The role of α-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling.
Shinde AV; Humeres C; Frangogiannis NG
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):298-309. PubMed ID: 27825850
[TBL] [Abstract][Full Text] [Related]
10. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
11. The role of Interleukin Receptor Associated Kinase (IRAK)-M in regulation of myofibroblast phenotype in vitro, and in an experimental model of non-reperfused myocardial infarction.
Saxena A; Shinde AV; Haque Z; Wu YJ; Chen W; Su Y; Frangogiannis NG
J Mol Cell Cardiol; 2015 Dec; 89(Pt B):223-31. PubMed ID: 26542797
[TBL] [Abstract][Full Text] [Related]
12. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction.
Small EM; Thatcher JE; Sutherland LB; Kinoshita H; Gerard RD; Richardson JA; Dimaio JM; Sadek H; Kuwahara K; Olson EN
Circ Res; 2010 Jul; 107(2):294-304. PubMed ID: 20558820
[TBL] [Abstract][Full Text] [Related]
13. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
[TBL] [Abstract][Full Text] [Related]
14. Regulators of cardiac fibroblast cell state.
Bretherton R; Bugg D; Olszewski E; Davis J
Matrix Biol; 2020 Sep; 91-92():117-135. PubMed ID: 32416242
[TBL] [Abstract][Full Text] [Related]
15. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.
Prabhu SD; Frangogiannis NG
Circ Res; 2016 Jun; 119(1):91-112. PubMed ID: 27340270
[TBL] [Abstract][Full Text] [Related]
16. Opposing Actions of Fibroblast and Cardiomyocyte Smad3 Signaling in the Infarcted Myocardium.
Kong P; Shinde AV; Su Y; Russo I; Chen B; Saxena A; Conway SJ; Graff JM; Frangogiannis NG
Circulation; 2018 Feb; 137(7):707-724. PubMed ID: 29229611
[TBL] [Abstract][Full Text] [Related]
17. The role of cardiac fibroblasts in post-myocardial heart tissue repair.
Chistiakov DA; Orekhov AN; Bobryshev YV
Exp Mol Pathol; 2016 Oct; 101(2):231-240. PubMed ID: 27619160
[TBL] [Abstract][Full Text] [Related]
18. The Ski-Zeb2-Meox2 pathway provides a novel mechanism for regulation of the cardiac myofibroblast phenotype.
Cunnington RH; Northcott JM; Ghavami S; Filomeno KL; Jahan F; Kavosh MS; Davies JJ; Wigle JT; Dixon IM
J Cell Sci; 2014 Jan; 127(Pt 1):40-9. PubMed ID: 24155330
[TBL] [Abstract][Full Text] [Related]
19. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction.
Dobaczewski M; Bujak M; Li N; Gonzalez-Quesada C; Mendoza LH; Wang XF; Frangogiannis NG
Circ Res; 2010 Aug; 107(3):418-28. PubMed ID: 20522804
[TBL] [Abstract][Full Text] [Related]
20. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
